| Literature DB >> 34945263 |
Hikaru Otsuka1, Hiroki Tabata2, Huicong Shi1, Hideyoshi Kaga3, Yuki Someya1,2,4, Abudurezake Abulaiti2, Hitoshi Naito3, Futaba Umemura1, Saori Kakehi2,3, Muneaki Ishijima1,2,5, Ryuzo Kawamori1,2,3, Hirotaka Watada2,3, Yoshifumi Tamura1,2,3,6,7.
Abstract
We investigated effects of exercise habits (EHs) in adolescence and old age on osteoporosis prevalence and hip joint and lumbar spine bone mineral density (BMD). Body composition and BMD in 1596 people aged 65-84 years living in Bunkyo-ku, Tokyo, were measured using dual-energy X-ray absorptiometry. We divided participants into four groups by a combination of EHs in adolescence and old age: none in either period (None-None), only in adolescence (Active-None), only in old age (None-Active), and in both periods (Active-Active). Logistic regression models were employed to estimate multivariable-adjusted odds ratios (ORs) for osteoporosis determined by T-score (less than -2.5 SD) using the None-None reference group. In men, the combination of EHs in adolescence and old age was not associated with osteoporosis prevalence. However, the lumbar spine's BMD was significantly higher in the Active-Active than the None-Active group (p = 0.043). In women, the Active-Active group had lower lumbar spine osteoporosis prevalence than the None-None group (OR 0.65; 95% CI, 0.42-1.00, p = 0.049). Furthermore, hip BMD was significantly higher in the Active-Active group than in the other three groups (p = 0.001). Older women with EHs in adolescence and old age had higher lumbar BMD and lower risk of osteoporosis.Entities:
Keywords: adolescence; bone mineral density; exercise habit; older adults; osteoporosis
Year: 2021 PMID: 34945263 PMCID: PMC8707562 DOI: 10.3390/jcm10245968
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of the participants.
Characteristics of the male participants.
| None-None | None-Active | Active-None | Active-Active | ||
|---|---|---|---|---|---|
| Number (%) | 86 (12.6) | 167 (24.5) | 153 (22.5) | 275 (40.1) | |
| Age (in years) | 74 (69–79) | 74 (69–78) | 72 (68–77) | 72 (68–76) b | |
| Height (cm) | 164.9 (161.3–168.3) | 165.4 (160.6–169.0) | 166.0 (162.1–170.1) | 166.2 (161.5–170.8) | |
| Bodyweight (kg) | 66.9 (62.0–71.3) | 63.3 (57.5–68.9) a | 66.6 (60.9–71.7) b | 64.9 (59.3–71.9) | |
| Body fat (%) | 19.1 (16.8–22.6) | 18.2 (15.6–21.7) | 18.1 (15.4–21.3) | 17.3 (14.5–19.8) a,b,c | |
| BMI (kg/m2) | 24.7 (23.0–26.0) | 23.6 (21.7–25.4) a | 23.8 (22.3–25.5) | 23.5 (21.9–25.5) a | |
| Calcium intake (mg/day) | 591 (470–786) | 604 (485–844) | 633 (477–821) | 673 (498–873) | |
| Alcohol intake (g/day) | 11.3 (0.00–32.4) | 7.59 (0.23–28.2) | 14.7 (0.00–39.4) | 16.7 (1.39–43.7) b | |
| Physical activity (METs hour/week) * | 19.8 (11.2–35.6) | 37.4 (23.1–37.2) a | 23.1 (13.2–37.2) b | 39.8 (23.1–67.2) a,c | |
| Current smoking ( | 12 (14.0) | 13 (7.8) | 29 (19.0) | 36 (13.1) | |
| Smoking history ( | 52 (60.5) | 116 (69.5) | 121 (79.1) | 208 (75.6) | |
| Taking osteoporosis medication ( | 1 (1.2) | 1 (0.6) | 1 (0.7) | 2 (0.7) | |
| Diabetes mellitus ( | 14 (16.3) | 28 (16.8) | 31 (20.3) | 50 (18.2) | |
| Hypertension ( | 36 (41.9) | 77 (46.1) | 79 (53.4) | 113 (43.0) | |
| Cancer ( | 9 (10.5) | 26 (15.6) | 36 (24.3) § | 38 (14.4) | |
| Osteoporosis—Hip Joint ( | 4 (4.7) | 8 (4.8) | 17 (11.1) | 17 (6.2) | |
| Osteoporosis—Lumbar spine ( | 1 (1.2) | 4 (2.4) | 7 (4.6) | 5 (1.8) | |
| Hip joint T-score (SD) | −0.8 (−1.6–−0.2) | −0.8 (−1.5–0.3) | −0.9 (−1.8–0.1) | −0.6 (−1.4–0.3) | |
| Lumbar spine T-score (SD) | 0.1 (−0.9–1.4) | 0.1 (−0.9–−1.1) | 0.4 (−0.8–1.6) | 0.5 (−0.5–1.8) b | |
| 25(OH)D (nmol/L) | 18.8 (16.0–22.0) | 20.0 (17.0–24.0) | 18.0 (15.0–22.2) b | 20.0 (17.0–24.0) a,c | |
| Glucose (mg/dL) | 94.0 (89.0–104.0) | 95.0 (90.0–104.0) | 95.5 (90.0–103.0) | 96.0 (90.0–105.0) | |
| HbA1c (%) | 5.6 (5.4–5.9) | 5.7 (5.5–5.7) | 5.7 (5.5–6.1) | 5.7 (5.5–6.0) | |
| Creatine (mg/dL) | 0.70 (0.61–0.81) | 0.71 (0.61–0.85) | 0.73 (0.64–0.87) | 0.71 (0.62–0.86) | |
| eGFR (mL/min) | 83.4 (69.6–97.0) | 82.1 (68.7–97.5) | 79.6 (67.1–91.4) | 82.4 (67.1–95.5) |
Values are presented as medians (interquartile range). BMI, body mass index; MET, metabolic equivalent of task. a p < 0.05, significant difference compared to the None-None group, b p < 0.05, significant difference compared to the None-Active group, c p < 0.05, significant difference compared to the Active-None group. * Physical activity was measured by IPAQ. § p < 0.05 significantly different for Chi-squared test.
Characteristics of the female participants.
| None-None | None-Active | Active-None | Active-Active | ||
|---|---|---|---|---|---|
| Number (%) | 159 (17.4) | 327 (35.7) | 144 (15.7) | 285 (31.1) | |
| Age (in years) | 72 (68–76) | 74 (69–78) | 73 (68–79) | 72 (68–77) b | |
| Height (cm) | 152.4 (149.2–155.9) | 152.0 (148.7–154.8) | 153.0 (149.1–156.8) | 153.1 (149.3–157.2) b | |
| Bodyweight (kg) | 53.4 (47.6–58.4) | 51.0 (46.4–55.2) a | 53.6 (48.1–61.4) b | 52.4 (47.5–56.8) | |
| Body fat (%) | 27.2 (23.2–31.4) | 25.9 (22.1–29.2) | 27.1 (23.4–30.5) | 25.8 (22.6–28.6) a | |
| BMI (kg/m2) | 23.0 (20.6–25.3) | 22.2 (20.2–24.1) | 23.1 (20.8–25.5) | 22.2(20.5–24.3) | |
| Calcium intake (mg/day) | 650 (453–823) | 725 (552–898) a | 637 (488–835) | 667(514–930) | |
| Alcohol intake (g/day) | 0.00 (0.00–1.17) | 0.00 (0.00–2.40) | 0.23 (0.00–3.47) | 0.47(0.00–6.62) | |
| Physical activity (METs hour/week) * | 23.1 (11.6–43.1) | 31.8 (18.6–52.2) a | 19.8 (9.90–39.6) b | 33.1(19.8–57.2) a.c | |
| Current smoking ( | 5 (3.1) | 8 (2.4) | 5 (3.5) | 12(4.2) | |
| Smoking history ( | 27 (17.0) | 46 (14.0) | 28 (19.4) | 59(20.7) | |
| Taking osteoporosis medication ( | 22 (13.8) | 60 (18.3) | 15 (10.4) | 34(11.9) | |
| Diabetes mellitus ( | 13 (8.2) | 27 (8.3) | 19 (13.2) | 22(7.7) | |
| Hypertension ( | 74 (46.5) | 154 (47.1) | 69 (48.6) | 122 (43.7) | |
| Cancer ( | 22 (13.8) | 41 (12.5) | 12 (16.3) | 29 (10.4) | |
| Osteoporosis—Hip Joint ( | 82 (51.6) | 185 (56.5) | 82 (56.9) | 132(46.3) | |
| Osteoporosis—Lumbar spine ( | 60 (37.7) | 124 (37.9) | 53 (36.8) | 91(31.9) | |
| Hip joint T-score (SD) | −2.4 (−3.0–−1.7) | −2.4 (−3.1–−1.8) | −2.5 (−3.1–−1.7) | −2.2(−2.8–−1.5) b,c | |
| Lumbar spine T-score (SD) | −1.8 (−2.5–−0.8) | −1.8 (−2.6–−0.8) | −1.5 (−2.5–−0.6) | −1.5(−2.4–−0.5) | |
| 25(OH)D (nmol/L) | 17.0 (14.1–21.0) | 18.0 (15.0–21.0) | 17.0 (14.8–21.0) | 18.0(15.0–21.5) | |
| Glucose (mg/dL) | 96.0 (90.0–107.0) | 96.0 (91.0–104.0) | 98.0 (91.0–104.0) | 98.0 (92.0–104.0) | |
| HbA1c (%) | 5.7 (5.5–6.0) | 5.7 (5.5–6.0) | 5.7 (5.5–6.1) | 5.7 (5.5–6.1) | |
| Creatine (mg/dL) | 0.7 (0.6–0.82) | 0.74 (0.63–0.86) | 0.76 (0.65–0.88) a | 0.75 (0.66–0.87) a | |
| eGFR (mL/min) | 63.1 (51.1–73.5) | 57.7 (48.8–69.3) | 55.0 (47.9–67.6) | 56.9 (48.6–66.7) |
Values are presented as medians (interquartile range). BMI, body mass index; MET, metabolic equivalent of task. a p < 0.05, significant difference compared to the None-None group, b p < 0.05, significant difference compared to the None-Active group, c p < 0.05, significant difference compared to the Active-None group. * Physical activity was measured by IPAQ.
Figure 2Comparison of bone mineral density (T-score) between the four exercise groups in men. (a) Hip joint T-score; (b) lumbar spine T-score. Values are the means ± SE. † p < 0.05 for significant difference between groups; b: compared to the None-Active group. Adjusted variables: Age, BMI, smoking history (current and past), alcohol intake, calcium intake, 25(OH)D, presence of diabetes, and taking osteoporosis drugs or estrogens.
Figure 3Comparison of the bone mineral density (T-score) between the four exercise groups in women. (a) Hip joint T-score; (b) lumbar spine T-score. Values are the means ± SE. † p < 0.05 for significant difference between groups; a: compared to the None-None group, b: compared to the None-Active group, c: compared to the Active-None group. Adjusted variables: Age, BMI, smoking history (current and past), alcohol intake, calcium intake, 25(OH)D, presence of diabetes, and taking osteoporosis drugs or estrogens.
Relationship between exercise habits (four groups) and the prevalence of osteoporosis in the hip joint and lumbar spine.
| Hip Joint | |||||
|---|---|---|---|---|---|
| Gender | Group | Crude | Model 1 | Model 2 | Model 3 |
| Male | None-None | 1.00 | 1.00 | 1.00 | 1.00 |
| None-Active | 1.03 (0.30–3.53) | 0.83 (0.24–2.90) | 0.82 (0.24–2.89) | 0.83 (0.24–2.94) | |
| Active-None | 2.56 (0.83–7.88) | 2.47 (0.79–7.70) | 2.77 (0.88–8.73) | 2.70 (0.86–8.53) | |
| Active-Active | 1.35 (0.44–4.13) | 1.21 (0.39–3.78) | 1.35 (0.43–4.25) | 1.37 (0.43–4.36) | |
| Female | None-None | 1.00 | 1.00 | 1.00 | 1.00 |
| None-Active | 1.22 (0.84–1.79) | 0.97 (0.65–1.45) | 0.96 (0.64–1.44) | 0.96 (0.64–1.45) | |
| Active-None | 1.24 (0.79–1.95) | 1.27 (0.78–2.07) | 1.27 (0.78–2.07) | 1.28 (0.78–2.09) | |
| Active-Active | 0.81 (0.60–1.20) | 0.69 (0.46–1.05) | 0.69 (0.46–1.05) | 0.70 (0.46–1.06) | |
|
| |||||
|
|
|
|
|
|
|
| Male | None-None | 1.00 | 1.00 | 1.00 | 1.00 |
| None-Active | 2.09 (0.23–18.96) | 1.51 (0.16–14.03) | 1.47 (0.16–13.80) | 1.27 (0.13–12.27) | |
| Active-None | 4.08 (0.49–33.69) | 3.37 (0.40–28.40) | 3.13 (0.37–26.57) | 3.42 (0.40–29.03) | |
| Active-Active | 1.57 (0.18–13.66) | 1.17 (0.13–10.40) | 1.10 (0.12–9.88) | 0.91 (0.09–8.53) | |
| Female | None-None | 1.00 | 1.00 | 1.00 | 1.00 |
| None-Active | 1.02 (0.70–1.51) | 0.81 (0.53–1.23) | 0.81 (0.53–1.23) | 0.79 (0.52–1.21) | |
| Active-None | 0.96 (0.60–1.53) | 0.95 (0.58–1.57) | 0.95 (0.57–1.56) | 0.97 (0.59–1.62) | |
| Active-Active | 0.77 (0.52–1.16) | 0.65 (0.42–1.00) | 0.65 (0.42–1.00) | 0.65 (0.42–1.00) | |
Data are expressed as odds ratios (95% CIs). Model 1 was adjusted for age and BMI. Model 2 was adjusted for the Model 1 covariates plus current and past smoking history. Model 3 was adjusted for the Model 2 covariates plus calcium intake, alcohol intake, 25(OH)D level, and diabetes.